News
MAYNF
2.030
-12.12%
-0.280
Mayne Pharma Secures Exclusive Australian Rights to Menopause Therapy Blissel
TipRanks · 09/15 00:15
Mayne Pharma Cancels Tranche of Performance Rights in Capital Management Move
TipRanks · 09/08 08:52
Mayne Pharma Issues New Shares Following Conversion of Unquoted Securities
TipRanks · 09/08 08:52
Mayne Pharma Earnings Call: Margins Rise, Risks Linger
TipRanks · 08/30 00:22
Mayne Pharma Seeks ASX Quotation for New Employee Incentive Shares
TipRanks · 08/28 08:04
Mayne Pharma Group reports FY results
Seeking Alpha · 08/27 11:06
Mayne Pharma Highlights FY26 Results and Risk Factors in Investor Update
TipRanks · 08/26 23:54
Mayne Pharma Posts FY26 Profit as Women’s Health and DistributeRx Drive Strategic Shift
TipRanks · 08/26 23:53
Mayne Pharma Swings to Full-Year Profit Despite Revenue Decline
TipRanks · 08/26 23:53
Mayne Pharma sets date for FY26 results release and investor webcast
TipRanks · 08/21 03:03
Mayne Pharma bolsters menopause portfolio with new IMVEXXY safety data and BIJUVA award recognition
TipRanks · 08/20 00:20
Mayne Pharma Launches Digital Investor Hub to Boost Shareholder Engagement
TipRanks · 08/17 23:33
Mayne Pharma Adds New Director With Significant Indirect Shareholding
TipRanks · 08/14 07:36
Mayne Pharma Publishes CEO Presentation for Bioshares Summit
TipRanks · 08/05 07:35
Mayne Pharma Reports Lapse of Performance Rights
TipRanks · 08/05 07:32
Mayne Pharma Issues New Shares Following Option Conversions
TipRanks · 08/05 07:32
Mayne Pharma Adds Major Shareholder Jacob Ma-Weaver to Board
TipRanks · 08/05 03:47
Mayne Pharma CEO to Present at 20th Bioshares Summit
TipRanks · 08/03 05:57
Mayne Pharma Group (MAYNF) Gets a Buy from Canaccord Genuity
TipRanks · 08/03 00:05
Mayne Pharma Issues New Unquoted Performance Rights Under Incentive Scheme
TipRanks · 07/06 22:27
More
Webull provides a variety of real-time MAYNF stock news. You can receive the latest news about Mayne Pharma Group Ltd through multiple platforms. This information may help you make smarter investment decisions.
About MAYNF
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others. Its subsidiaries include Mayne Pharma International Pty Ltd, Mayne Holdings US Inc, Mayne Pharma LLC, and others.